跳至主要内容
临床试验/NCT00001813
NCT00001813已完成不适用

Examination of Clinical and Laboratory Abnormalities in Patients With Defective DNA Repair: Xeroderma Pigmentosum, Cockayne Syndrome, or Trichothiodystrophy

National Cancer Institute (NCI)1 个研究点 分布在 1 个国家目标入组 709 人开始时间: 1999年5月10日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
709
试验地点
1
主要终点
Identify patients with genetic diseases

研究概览

简要总结

Four rare genetic diseases, xeroderma pigmentosum (XP), Cockayne syndrome (CS), the XP/CS complex and trichothiodystrophy (TTD) have defective DNA excision repair although only XP has increased cancer susceptibility. We plan to perform careful clinical examination of selected patients with XP, XP/CS, CS, or TTD and follow their clinical course. We will obtain tissue (skin, blood, hair, buccal swabs) for laboratory examination of DNA repair and for genetic analysis. We hope to be able to correlate these laboratory abnormalities with the clinical features to better understand the mechanism of cancer prevention by DNA repair. Patients will be offered counseling and education for cancer control....

详细描述

Three rare genetic diseases, xeroderma pigmentosum (XP), Cockayne syndrome (CS), and trichothiodystrophy (TTD) have defective DNA excision repair although only XP has increased cancer susceptibility. We plan to perform careful clinical examination of selected patients with XP, CS, TTD, or overlap syndromes to follow their clinical course. We will obtain tissue (skin, blood, hair, or buccal cells) for laboratory examination of DNA repair and for histologic, protein, biochemical, and genetic analysis. We hope to be able to correlate these laboratory abnormalities with the clinical features to better understand the mechanism of cancer prevention by DNA repair. Patients will be offered counseling and education for cancer control.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
6 Weeks 至 100 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • INCLUSION CRITERIA:
  • Subjects age 6 weeks and above:
  • with clinical and/or laboratory documentation of typical features or suggestive clinical features of XP, CS, TTD, or overlap syndromes or
  • that are first degree relatives or other family members of participants with XP, CS, TTD, or overlap syndromes
  • Healthy volunteers of age 1 year and above (including NIH employees) willing to donate blood, skin, buccal cells, or hair.
  • Patients or legally authorized representatives must provide informed consent.

排除标准

  • Inability or unwillingness to provide tissue (skin, blood, buccal cells or hair) for laboratory studies.

研究组 & 干预措施

2

Family members of patients with XP, CS, TTD, or overlap syndromes

3

Healthy volunteers

1

Subjects with clinical and/or laboratory documentation of typical features or suggestiveclinical features of XP, CS, TTD, or overlap syndromes

结局指标

主要结局

Identify patients with genetic diseases

时间窗: Up to 3 days

Proportion of patients with three rare genetic diseases; xeroderma pigmentosum (XP), Cockayne syndrome (CS), and trichothiodystrophy (TTD)and overlap syndromes

次要结局

  • Diagnosis confirmation(up to 3 days)
  • identify molecular defects(up to 3 days)
  • Tissue collection(up to 3 days)
  • overall survival(yearly)

研究者

申办方类型
Nih
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验